Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V - Ferrannini, Giulia; De Bacquer, Dirk; De Backer, Guy; Kotseva, Kornelia; Mellbin, Linda; Wood, David; Rydén, Lars; Gale, Christopher P.; Beleslin, Branko; Budaj, Andrzej; Chioncel, Ovidiu; Dagres, Nikolaos; et al. (Diabetes care, 2020)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose - analysis; Blood Glucose - metabolism; Cardiology; Cardiovascular disease; Cardiovascular diseases; Complications; Coronary artery; Coronary artery disease; Coronary Artery Disease - blood; Coronary Artery Disease - complications; Coronary Artery Disease - epidemiology; Coronary Artery Disease - therapy; Coronary vessels; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - diagnosis; Diabetes Mellitus, Type 2 - epidemiology; Diabetes Mellitus, Type 2 - prevention & control; Europe - epidemiology; Female; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Glucose; Glucose Intolerance - complications; Glucose Intolerance - diagnosis; Glucose Intolerance - epidemiology; Glucose Intolerance - therapy; Glucose metabolism; Glucose Metabolism Disorders - complications; Glucose Metabolism Disorders - diagnosis; Glucose Metabolism Disorders - epidemiology; Glucose Metabolism Disorders - therapy; Glucose tolerance; Glucose Tolerance Test; Health risks; Health Services Needs and Demand - organization & administration; Health Services Needs and Demand - standards; Heart diseases; Hemoglobin; Humans; Life expectancy; Life span; Male; Management; Mass Screening - methods; Mass Screening - standards; Middle Aged; Polls & surveys; Primary Prevention - methods; Primary Prevention - organization & administration; Primary Prevention - standards; Program Evaluation; Quality Improvement; Research design; Risk analysis; Risk Factors; Risk management; Sodium-glucose cotransporter; Young Adult; Europe